157 related articles for article (PubMed ID: 37600426)
1. Developing diagnostic criteria to differentiate fungal foot infections caused by
Leeyaphan C; Chai-Adisaksopha C; Tovanabutra N; Phinyo P; Bunyaratavej S
Heliyon; 2023 Aug; 9(8):e18963. PubMed ID: 37600426
[TBL] [Abstract][Full Text] [Related]
2. Prognostic factors for mycological cure in patients with onychomycosis caused by Neoscytalidium dimidiatum: A retrospective cohort study.
Leeyaphan C; Chai-Adisaksopha C; Tovanabutra N; Phinyo P; Bunyaratavej S
Mycoses; 2023 Jun; 66(6):497-504. PubMed ID: 36740753
[TBL] [Abstract][Full Text] [Related]
3. Allergic fungal rhinosinusitis caused by Neoscytalidium dimidiatum: A case report: Allergic fungal rhinosinusitis due to Neoscytalidium dimidiatum.
Raiesi O; Hashemi SJ; Yarahmadi M; Getso MI; Raissi V; Amiri S; Borjian Boroujeni Z
J Mycol Med; 2022 Mar; 32(1):101212. PubMed ID: 34758426
[TBL] [Abstract][Full Text] [Related]
4. Distinct characteristics of Scytalidium dimidiatum and non-dermatophyte onychomycosis as compared with dermatophyte onychomycosis.
Bunyaratavej S; Prasertworonun N; Leeyaphan C; Chaiwanon O; Muanprasat C; Matthapan L
J Dermatol; 2015 Mar; 42(3):258-62. PubMed ID: 25639524
[TBL] [Abstract][Full Text] [Related]
5. In Vitro Antifungal Susceptibility of Neoscytalidium dimidiatum Clinical Isolates from Malaysia.
James JE; Santhanam J; Lee MC; Wong CX; Sabaratnam P; Yusoff H; Tzar MN; Razak MF
Mycopathologia; 2017 Apr; 182(3-4):305-313. PubMed ID: 27815659
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of 5% amorolfine nail lacquer in Neoscytalidium dimidiatum onychomycosis.
Bunyaratavej S; Leeyaphan C; Rujitharanawong C; Surawan TM; Muanprasat C; Matthapan L
J Dermatolog Treat; 2016 Aug; 27(4):359-63. PubMed ID: 26471716
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of foot diseases in outpatients attending the Institute of Dermatology, Bangkok, Thailand.
Ungpakorn R; Lohaprathan S; Reangchainam S
Clin Exp Dermatol; 2004 Jan; 29(1):87-90. PubMed ID: 14723731
[TBL] [Abstract][Full Text] [Related]
8. Onychomycosis caused by the environmental mold Neoscytalidium dimidiatum in Colombia, and in vitro antifungal susceptibility evaluation.
Gil-González M; Gómez-Velásquez JC; Loaiza-Díaz N; Florez-Muñoz SV; Hernández-Herrera GN; Mesa-Arango AC
Med Mycol; 2020 Dec; ():. PubMed ID: 33369622
[TBL] [Abstract][Full Text] [Related]
9. First Isolation of Neoscytalidium dimidiatum from Human Dermatomycosis in Japan.
Futatsuya T; Ogawa A; Anzawa K; Mochizuki T; Shimizu A
Med Mycol J; 2022; 63(3):71-75. PubMed ID: 36047185
[TBL] [Abstract][Full Text] [Related]
10. Cutaneous Fungal Infections Caused by Dermatophytes and Non-Dermatophytes: An Updated Comprehensive Review of Epidemiology, Clinical Presentations, and Diagnostic Testing.
Chanyachailert P; Leeyaphan C; Bunyaratavej S
J Fungi (Basel); 2023 Jun; 9(6):. PubMed ID: 37367605
[TBL] [Abstract][Full Text] [Related]
11. Successful identification of clinical dermatophyte and Neoscytalidium species by matrix-assisted laser desorption ionization-time of flight mass spectrometry.
Alshawa K; Beretti JL; Lacroix C; Feuilhade M; Dauphin B; Quesne G; Hassouni N; Nassif X; Bougnoux ME
J Clin Microbiol; 2012 Jul; 50(7):2277-81. PubMed ID: 22535981
[TBL] [Abstract][Full Text] [Related]
12. In vitro biofilms and antifungal susceptibility of dermatophyte and non-dermatophyte moulds involved in foot mycosis.
Toukabri N; Corpologno S; Bougnoux ME; El Euch D; Sadfi-Zouaoui N; Simonetti G
Mycoses; 2018 Feb; 61(2):79-87. PubMed ID: 28940733
[TBL] [Abstract][Full Text] [Related]
13. Epidemiology of superficial fungal diseases in French Guiana: a three-year retrospective analysis.
Simonnet C; Berger F; Gantier JC
Med Mycol; 2011 Aug; 49(6):608-11. PubMed ID: 21314249
[TBL] [Abstract][Full Text] [Related]
14. Sertaconazole: a review of its use in the management of superficial mycoses in dermatology and gynaecology.
Croxtall JD; Plosker GL
Drugs; 2009; 69(3):339-59. PubMed ID: 19275277
[TBL] [Abstract][Full Text] [Related]
15. Cutaneous murine model of infection caused by Neoscytalidium dimidiatum: a preliminary study of an emerging human pathogen.
da Silva RT; Guimarães DA; Camargo ZP; Rodrigues AM; Maceira JP; Bernardes-Engemann AR; Orofino-Costa R
Med Mycol; 2016 Nov; 54(8):890-8. PubMed ID: 27250925
[TBL] [Abstract][Full Text] [Related]
16. Deep Cutaneous Neoscytalidium dimidiatum Infection: Successful Outcome with Amphotericin B Therapy.
Yang SJ; Ng CY; Wu TS; Huang PY; Wu YM; Sun PL
Mycopathologia; 2019 Feb; 184(1):169-176. PubMed ID: 30515655
[TBL] [Abstract][Full Text] [Related]
17. Epidemiology of dermatomycoses and onychomycoses in Ireland (2001-2020): A single-institution review.
Powell J; Porter E; Field S; O'Connell NH; Carty K; Dunne CP
Mycoses; 2022 Jul; 65(7):770-779. PubMed ID: 35598177
[TBL] [Abstract][Full Text] [Related]
18. [Molecular biological detection of dermatophytes in clinical samples when onychomycosis or tinea pedis is suspected. A prospective study comparing conventional dermatomycological diagnostics and polymerase chain reaction].
Winter I; Uhrlaß S; Krüger C; Herrmann J; Bezold G; Winter A; Barth S; Simon JC; Gräser Y; Nenoff P
Hautarzt; 2013 Apr; 64(4):283-9. PubMed ID: 23532505
[TBL] [Abstract][Full Text] [Related]
19. Performance of mycology and histopathology tests for the diagnosis of toenail onychomycosis due to filamentous fungi: Dermatophyte and non-dermatophyte moulds.
Lavorato FG; Guimarães DA; Premazzi MG; Piñeiro-Maceira JM; Bernardes-Engemann AR; Orofino-Costa R
Mycoses; 2017 Sep; 60(9):587-593. PubMed ID: 28504456
[TBL] [Abstract][Full Text] [Related]
20. Prevalence and epidemiology of tinea pedis and toenail onychomycosis and antifungal susceptibility of the causative agents in patients with type 2 diabetes in Turkey.
Oz Y; Qoraan I; Oz A; Balta I
Int J Dermatol; 2017 Jan; 56(1):68-74. PubMed ID: 27667305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
